EIB – Germany: EIB and European Commission provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing

European Investment Bank and CureVac sign €75 million loan agreement for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against SARS-CoV-2 The EIB loan will support CureVac’s https://cfi.co/c-19-press/2020/07/eib-germany-eib-and-european-commission-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing/ https://cfi.co/c-19-press/2020/07/eib-germany-eib-and-european-commission-provide-curevac-with-a-e75-million-financing-for-vaccine-development-and-expansion-of-manufacturing/